MSX-122 (Q-122) is a novel CXCR4 partial antagonist with an IC50 of about 10 nM.

 

Brand: BCM

 

Target: CXCR

 

Signaling Pathways: Autophagy; GPCR/G Protein; Immunology/Inflammation

 

Melting Point: 219 °C

 

Boiling Point: 566.9±60.0 °C(Predicted)

 

pKa: 3.82±0.10(Predicted)

 

Solubility: Soluble in DMSO. Insoluble in Water; Insoluble in Ethanol.

 

GHS: GHS05, GHS08

 

Isomeric SMILES: C1=CN=C(N=C1)NCC2=CC=C(C=C2)CNC3=NC=CC=N3  

 

InChIKey: PXZXYRKDDXKDTK-UHFFFAOYSA-N  

 

InChI: InChI=1S/C16H16N6/c1-7-17-15(18-8-1)21-11-13-3-5-14(6-4-13)12-22-16-19-9-2-10-20-16/h1-10H,11-12H2,(H,17,18,21)(H,19,20,22)

 

Attribute
[Chem Name]	N-[[4-[(pyrimidin-2-ylamino)methyl]phenyl]methyl]pyrimidin-2-amine
[Synonym]	MSX-122; Q-122
[CAS No.]	897657-95-3
[MDL No.]	MFCD18803971
[Formula]	C16H16N6
[Molecular]	292.35
[Form]	A crystalline solid
[Storage]	Sealed in dry. Stored at -20°C.

Goods Tag